Tonic App - New Investment
We are delighted to welcome our new subsidiary, Tonic App, to continue our 2024 objective of investing in emerging markets focused on new trends that promise to revolutionise reality as we know it now.
The Tonic App aims to become the first medical platform with a presence in the largest European health markets, namely Spain, Italy and France, where it already operates, followed by the United Kingdom and Germany, which it plans to enter over the next 24 months.
The growing number of medical tools and clinical content available, certification as a medical device, validation of its content and the recent launch of a virtual assistant powered by artificial intelligence - Dr Tonic - are just some of the milestones achieved by the start-up.
Read the story in Jornal de Negócios.
